A pharmaceutical company's GMP certificate recovered is suspected to be related to the detected dye

Finishing: Dandelion Yuxuan On November 28, 2019, the Provincial Bureau carried out a cause (flight) inspection on the GMP of Anhui Boyuan pharmaceutical Yinpian Co., Ltd and found two serious defects The GMP certificate of the enterprise was withdrawn according to law On November 26, the State Drug Administration issued a notice saying that after the inspection of Gansu drug inspection and Research Institute, a batch of blood exhaustion produced by Anhui Boyuan pharmaceutical decoction pieces Co., Ltd (hereinafter referred to as Boyuan pharmaceutical) did not meet the requirements, and 808 scarlet and rosin acid were detected According to surging news reports, on November 26, the Anhui Provincial Food and drug administration dispatched relevant experts to set up an investigation team, which will go to the enterprises involved for field investigation It needs to be investigated to find out the specific problems such as "how much is sold and where is used" of the current non-conforming batches of blood exhaustion Two days later, the enterprise was withdrawn GMP certificate, involving two serious defects, and the reason for receipt was not disclosed On November 26, 2019, the State Drug Administration announced on its official website that 57 batches of drugs were found to be unqualified after inspection by relevant drug inspection agencies Among them, one batch of dried blood produced by Anhui Boyuan pharmaceutical Yinpian Co., Ltd (hereinafter referred to as Boyuan pharmaceutical) did not meet the requirements, and 808 scarlet red and rosin acid were detected after inspection by Gansu pharmaceutical inspection and Research Institute On December 7, 2016, the General Administration of food and drug issued a circular (2016 No 159) on the detection of rosin acid or 808 scarlet red in 6 batches of drugs from 5 enterprises including Jilin Yongli Pharmaceutical Co., Ltd It was found that rosin acid was detected in Diedahuoxue powder marked as batch No 20140404 and 20150101 produced by Jilin Yongli Pharmaceutical Co., Ltd., 20150101 produced by Jilin Dongfeng Pharmaceutical Co., Ltd and 140201 produced by Jilin Shuangshi Pharmaceutical Co., Ltd It was found that 808 scarlet was detected in the 25th flavor coral pill with the batch numbers of 20150407 and 131001, respectively, which was marked as produced by Jinhe Tibetan Medicine Co., Ltd and Tibet jinzhuyalong Tibetan Medicine Co., Ltd On February 14, 2015, the State Food and Drug Administration issued the notice on detection of Sudan red or rosin acid in products of seven enterprises including Shanxi wanglongshen Pesticide Industry Co., Ltd, Food and Drug Administration of the people's Republic of China has organized special supervision and sampling inspection on two kinds of rheumatoid arthritis tablets and Dida pills nationwide 158 batches of Dida pills and 155 batches of rheumatoid arthritis tablets have been selected from the production, marketing and use of drugs.